PDI - Resultado de Búsqueda

Jana Stojanova

Profesor Auxiliar

Universidad de Valparaíso

Viña del Mar, Chile

Post-transplant lymphoproliferative disease; immunosuppressants; transplantation; pharmacogenetics; pharmacokinetics; epidemiology; design and execution of clinical research

PhD Biology-Health, Pharmacology, UNIVERSIDAD DE LIMOGES. Francia, 2013
Pharmacy, UNIVERSITY OF SYDNEY. Australia, 2006
Quimico Farmaceutico, UNIVERSIDAD DE CHILE. Chile, 2018

Clinical Coordinator Full Time

UNIVERSIDAD DE VALPARAISO

Chile

2015 - 2019
Editorial Coordinator Part Time

UNIVERSIDAD DE CHILE

Chile

2013 - 2015
Research Assistant Part Time

UNIVERSIDAD DE CHILE

Chile

2014 - 2015
Profesor Auxiliar Part Time

UNIVERSIDAD DE VALPARAISO

Medicine

Chile

2020 - At present

Clinical Pharmacist Full Time

The Canberra Hospital

Australia

2006 - 2009
Doctoral Contract Full Time

Université de Limoges

Francia

2009 - 2013
Learning and Support Officer (Group Staff) Part Time

Cochrane

Reino Unido

2020 - At present

Apoyo en diseño metodologico y ejecución para validación clínica de varios proyectos de innovación, apoyados por Corfo, Fondef, MINEDUC


General concepts in biostatistics and clinical epidemiology: Experimental studies with randomized clinical trial design. Article ISI SCOPUS Medwave (2020)
How to design a study to evaluate therapeutic drug monitoring in infectious diseases? Sturkenboom MG Article SCOPUS Clinical Microbiology and Infection (2020)
Main concepts on bioequivalence and biosimilarity in the Chilean legislation, and current controversies on drug interchangeability. Article ISI SCOPUS Medwave (2020)
Psychotropic drug concentrations and clinical outcomes in children and adolescents Article EXPERT OPINION ON DRUG SAFETY (2020)
Default Mode Network, Meditation, and Age-Associated Brain Changes: What Can We Learn from the Impact of Mental Training on Well-Being as a Psychotherapeutic Approach? Arancibia, Marcelo; Aspe-Sanchez, Mauricio; Cordova,Claudio; Henriquez-Ch, Rodrigo A. Article ISI SCOPUS NEURAL PLASTICITY (2019)
General concepts in biostatistics and clinical epidemiology: observational studies with case-control design. Article MEDWAVE (2019)
General concepts in biostatistics and clinical epidemiology: Observational studies with cross-sectional and ecological designs. Article MEDWAVE (2019)
Placental structure in gestational diabetes mellitus Article BIOCHIMICA ET BIOPHYSICA ACTA (2019)
Using systematic reviews in the scientific substantiation of health properties of foods and food constituents. Article MEDWAVE (2019)
Corneal endothelial cell loss associated to phacoemulsification and ophthalmologist experience: prospective analysis of individual secondary data Chamorro, Fernando; Briones, Cristobal; Leon, Alex; Arancibia, Marcelo; Stojanova, Jana; Madrid, Eva Article WOS-ESCI SCOPUS MEDWAVE (2018)
Therapeutic drug monitoring: More than avoiding toxicity Stojanova J.; Luque S. Article SCOPUS Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill (2017)
A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation Pouché L.; Koitka M.; Stojanova J.; Monchaud C.; Villeneuve C.; Essig M.; Abraham J.; Le Meur Y.; Rerolle J.-P.; Kamar N.; et al. Article ISI SCOPUS PHARMACOGENOMICS (2016)
Genetic polymorphisms in the immune response: A focus on kidney transplantation Stojanova J.; Pouché L.; Picard N. Article ISI SCOPUS CLINICAL BIOCHEMISTRY (2016)
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections Lamoureux, F; Duflot, T; Woillard, JB; Metsu, D; Pereira, T.; Compagnon, P; Morisse-Pradier, H; El Kholy, M; Thiberville, L.; Stojanova J.; et al. Article ISI SCOPUS INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses Varela N.; Quiñones, LA; Stojanova J.; Garay J.; Caceres D.; Cespedes S.; Sasso, J.; Miranda C. Article ISI SCOPUS Pharmacological Research (2015)
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants Caillard, Sophie; Rousseau, Annick; Marquet, Pierre Article ISI PHARMACOLOGICAL RESEARCH (2011)
The FcγRIIIA‐158 VV genotype increased the risk of post‐transplant lymphoproliferative disorder in T‐cell depleted kidney transplant recipients. Gatault P; Lajoie L Article TRANSPLANT INTERNATIONAL


Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses (vol 101, pg 124, 2015) Varela N.; Stojanova J.; Garay J.; Caceres D.; Cespedes S.; Sasso, J.; Miranda C. Errata ISI SCOPUS PHARMACOLOGICAL RESEARCH (2016)


New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs Pouché L.; Stojanova J.; Marquet P.; Picard N. Review ISI SCOPUS PHARMACOGENOMICS (2016)
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy? Roco A.; Cayun J; Contreras S.; Stojanova J.; Quiñones, L Review ISI SCOPUS Frontiers in Genetics (2014)